First Affiliated Hospital of Xiamen University

Xiamen 361003

3 studies enrolling now · 7 studies all time

What they study most

Atrial Fibrillation, Extrapulmonary Neuroendocrine Cancer (epNEC), Interstitial Lung Diseases, Lung Cancer, Non-squamous, Non-small Cell, Neoplasm Metastasis, Non-Small Cell Lung Cancer, Secondary Prevention, Stroke, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases, Systemic Sclerosis

Studies at this site

• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — Running, not enrolling
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed